Neoadjuvant Platform Trial in Non-Small Cell Lung Cancer
Clinical trial NCT05714891 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05714891
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2026-08-31
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.